Gia Nemsadze

Gia Nemsadze

Petre Shotadze Tbilisi Medical Academy - Tbilisi / Georgia
Others
AD Scientific Index ID: 1712447
თბილისის სამედიცინო აკადემია
person_outline Gia Nemsadze's MOST POPULAR ARTICLES
1-) Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: the PAKT trialP Schmid, J Abraham, S Chan, D Wheatley, AM Brunt, G Nemsadze, ...Journal of Clinical Oncology 38 (5), 423-433, 20201942020
2-) Effect of a proposed trastuzumab biosimilar compared with trastuzumab on overall response rate in patients with ERBB2 (HER2)–positive metastatic breast cancer: a randomized …HS Rugo, A Barve, CF Waller, M Hernandez-Bronchud, J Herson, J Yuan, ...Jama 317 (1), 37-47, 20171492017
3-) Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trialM Gogishvili, T Melkadze, T Makharadze, D Giorgadze, M Dvorkin, ...Nature Medicine 28 (11), 2374-2380, 2022932022
4-) Fulvestrant plus vistusertib vs fulvestrant plus everolimus vs fulvestrant alone for women with hormone receptor–positive metastatic breast cancer: the MANTA phase 2 randomized …P Schmid, M Zaiss, C Harper-Wynne, M Ferreira, S Dubey, S Chan, ...JAMA oncology 5 (11), 1556-1564, 2019932019
5-) AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled …P Schmid, J Abraham, S Chan, D Wheatley, M Brunt, G Nemsadze, ...J Clin Oncol 36 (15_suppl), 1007, 2018792018